Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

VIR holding history

Vir Biotechnology, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VIR overviewAll 13F holders of VIRFull Q2 2026 holdings

Shares (Q2 2026)
23,043
Value
$234.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VIR by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202623,043$234.8K<0.1%+1,275+5.9%AddedHolders
Q1 202621,768$195.0K<0.1%−1,757−7.5%ReducedHolders
Q4 202523,525$141.9K<0.1%+1,705+7.8%AddedHolders
Q3 202521,820$124.6K<0.1%−3,285−13.1%ReducedHolders
Q2 202525,105$126.5K<0.1%−2,486−9.0%ReducedHolders
Q1 202527,591$178.8K<0.1%−5,972−17.8%ReducedHolders
Q4 202433,563$246.4K<0.1%+6,767+25.3%AddedHolders
Q3 202426,796$200.7K<0.1%+5,441+25.5%AddedHolders
Q2 202421,355$190.1K<0.1%−5,037−19.1%ReducedHolders
Q1 202426,392$267.4K<0.1%+2,035+8.4%AddedHolders
Q4 202324,357$245.0K<0.1%+2,789+12.9%AddedHolders
Q3 202321,568$202.1K<0.1%+13+0.1%AddedHolders
Q2 202321,555$528.7K<0.1%+1,693+8.5%AddedHolders
Q1 202319,862$462.2K<0.1%−3,841−16.2%ReducedHolders
Q4 202223,703$599.9K<0.1%+1,288+5.7%AddedHolders
Q3 202222,415$431.0K<0.1%+619+2.8%AddedHolders
Q2 202221,796$556.0K<0.1%−4,843−18.2%ReducedHolders
Q1 202226,639$685.0K<0.1%−6,759−20.2%ReducedHolders
Q4 202133,398$1.40M<0.1%−3,941−10.6%ReducedHolders
Q3 202137,339$1.63M<0.1%−4,018−9.7%ReducedHolders
Q2 202141,357$1.96M<0.1%+8,126+24.5%AddedHolders
Q1 202133,231$1.70M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.